Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.52 |
| ▸ | RAB9A | P51151 | 5/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.49 |
| ▸ | MLYCD | O95822 | 2/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3957622 | 0.80 | RAB9A (0.58) | NPC1RAB9AEGLN1MLYCDL3MBTL1 | |
| SCHEMBL28213665 | 0.75 | NPC1 (0.56) | NPC1RAB9AMLYCD | |
| SCHEMBL13073725 | 0.74 | NPC1 (0.66) | NPC1RAB9AMLYCDHDAC4HDAC3 | |
| SCHEMBL1178776 | 0.74 | HTT (0.59) | NPC1RAB9ATAAR1MLYCDHDAC4 | |
| SCHEMBL29883463 | 0.73 | GABRP (0.55) | L3MBTL1 | |
| SCHEMBL5320191 | 0.72 | NPC1 (0.67) | NPC1RAB9AL3MBTL1HDAC6 | |
| SCHEMBL13541971 | 0.72 | TAAR1 (0.54) | NPC1RAB9ATAAR1MLYCDHDAC4 | |
| SCHEMBL27894530 | 0.71 | NPC1 (0.56) | NPC1RAB9AMLYCDHDAC4HDAC3 | |
| SCHEMBL3062674 | 0.70 | MLYCD (0.76) | NPC1RAB9ATAAR1MLYCDHDAC4 | |
| SCHEMBL16352053 | 0.69 | RAB9A (0.62) | NPC1RAB9AEGLN1L3MBTL1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2079739-A2 | PYRIDO[4,3-D]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS | Pfizer Products Inc. (US) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008041118-A2 | PYRIDO[4,3-D]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS | PFIZER PRODUCTS INC. (US) | 2008-04-10 | — | — | WO | disclosed |